INVIVO THERAPEUTICS HOLDINGS CORP. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events

On June 2, 2022, InVivo Therapeutics Holdings Corp. (the "Company") issued a press release announcing that the Company has completed enrollment in its INSPIRE 2.0 Study for acute spinal cord injury. A copy of this press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference to this Item 8.01.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



Exhibit
No.        Description
  99.1       Press Release, dated June 2, 2022, of InVivo Therapeutics Holdings Corp.
104        Cover Page Interactive Data File (formatted as Inline XBRL).

© Edgar Online, source Glimpses